Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Myeloproliferative Neoplasms ORLANDO, FLORIDA / ACCESS Newswire / January 7, 2026 / The Assistance Fund, an ...
The Middle star Pat Finn's cause of death has been revealed two weeks after his passing on December 22, 2025 at the age of 60 ...
CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...
Long-term surveillance of branch-duct IPMN shows a 5.5% 10-year risk for pancreatic cancer, with cyst wall thickening emerging as a key independent predictor.
Histological analysis of the resected specimen diagnosed a Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) with mild lymphocytic submucosal inflammation. Crucially, there was no ...
In this segment, Dr Luskin examines how patient-related factors influence treatment decisions in blastic plasmacytoid ...
ISCHAEMIC heart diseases remained the leading cause of death in the Philippines from January to June 2025, followed by ...
When I was about 6 years old in the early ‘40s, my 16-year-old brother was sent to a sanitarium for tuberculosis patients. He ...
Intense pain during a bowel movement sent our son to the ER. He got diagnosed with a blood clot in a hemorrhoid and needed surgery to fix it.
JAK2 inhibitors (JAK2i) are the standard treatment for myelofibrosis (MF), offering symptom relief and reducing spleen size. However, all FDA-approved JAK2i are type I inhibitors, which fail to ...
AbbVie ABBV has been consistently increasing its R&D investments to support long-term growth across multiple therapeutic areas. The company’s pipeline spans immunology therapies, expanding oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback